Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons
Identifieur interne : 003283 ( Main/Exploration ); précédent : 003282; suivant : 003284Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons
Auteurs : Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France]Source :
- Brain research [ 0006-8993 ] ; 2003.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
It is well documented that VMAT2 protects nigrostriatal DA neurons against MPP by sequestering it inside vesicles away from its mitochondrial site of neurotoxic action. However, the implication of the VMAT2 in the mechanism of action exerted by 6-OHDA has received little attention. Therefore, the aim of the present study was to determine whether the vesicular sequestration of 6-OHDA would protect dopaminergic neurons from its toxicity similarly to what is observed with MPP+, We injected mice with 6-OHDA 90 min after TBZ treatment. Since, unexpectedly, TBZ pretreatment prevented 6-OHDA neurotoxicity, we performed a similar experience replacing 6-OHDA with MPP in order to check our experimental protocol. TBZ pretreatment similarly prevented MPP neurotoxicity. This discrepancy with what is commonly describe in the literature, led us to use reserpine. Indeed, the long lasting VMAT2 inhibition induced by reserpine allowed us to inject neurotoxins while mice no longer presented hypothermia. Contrary to TBZ pretreatment, reserpine pretreatment potentiated both 6-OHDA and MPP+ toxicity on dopaminergic neurons. Hypothermia elicited by TBZ appeared to be responsible, at least in part, for the neuroprotective effect observed. To verify this hypothesis, we investigated the influence of hypothermia on the toxic activity of both neurotoxins. A hypothermia similar to that induced by TBZ was obtained by a forced swimming test of putting mice into cool water (23 °C). The hypothermia prevented both 6-OHDA and MPP+-induced neurotoxicity. We finally reported that VMAT2 inhibition potentiates both MPP+ and 6-OHDA neurotoxicity.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000E74
- to stream PascalFrancis, to step Curation: 000560
- to stream PascalFrancis, to step Checkpoint: 000E09
- to stream Main, to step Merge: 003772
- to stream Main, to step Curation: 003283
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons</title><author><name sortKey="Cleren, Carine" sort="Cleren, Carine" uniqKey="Cleren C" first="Carine" last="Cleren">Carine Cleren</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Naudin, Bertrand" sort="Naudin, Bertrand" uniqKey="Naudin B" first="Bertrand" last="Naudin">Bertrand Naudin</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Costentin, Jean" sort="Costentin, Jean" uniqKey="Costentin J" first="Jean" last="Costentin">Jean Costentin</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">04-0022513</idno><date when="2003">2003</date><idno type="stanalyst">PASCAL 04-0022513 INIST</idno><idno type="RBID">Pascal:04-0022513</idno><idno type="wicri:Area/PascalFrancis/Corpus">000E74</idno><idno type="wicri:Area/PascalFrancis/Curation">000560</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000E09</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000E09</idno><idno type="wicri:doubleKey">0006-8993:2003:Cleren C:apparent:opposite:effects</idno><idno type="wicri:Area/Main/Merge">003772</idno><idno type="wicri:Area/Main/Curation">003283</idno><idno type="wicri:Area/Main/Exploration">003283</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons</title><author><name sortKey="Cleren, Carine" sort="Cleren, Carine" uniqKey="Cleren C" first="Carine" last="Cleren">Carine Cleren</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Naudin, Bertrand" sort="Naudin, Bertrand" uniqKey="Naudin B" first="Bertrand" last="Naudin">Bertrand Naudin</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author><author><name sortKey="Costentin, Jean" sort="Costentin, Jean" uniqKey="Costentin J" first="Jean" last="Costentin">Jean Costentin</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unite de Neuropsychopharmacologie Expérimentale, UMR 6036 CNRS, IFRMP 23, 22 Boulevard Gambetta</s1><s2>76183 Rouen</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Rouen</settlement></placeName></affiliation></author></analytic><series><title level="j" type="main">Brain research</title><title level="j" type="abbreviated">Brain res.</title><idno type="ISSN">0006-8993</idno><imprint><date when="2003">2003</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Brain research</title><title level="j" type="abbreviated">Brain res.</title><idno type="ISSN">0006-8993</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term><term>Corpus striatum</term><term>Dopaminergic neuron</term><term>Locus niger</term><term>Mouse</term><term>Oxidopamine</term><term>Parkinson disease</term><term>Reserpine</term><term>Tetrabenazine</term><term>Toxicity</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Corps strié</term><term>Locus niger</term><term>Neurone dopaminergique</term><term>Réserpine</term><term>Tétrabénazine</term><term>Parkinson maladie</term><term>Toxicité</term><term>Oxidopamine</term><term>Souris</term><term>Animal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">It is well documented that VMAT2 protects nigrostriatal DA neurons against MPP by sequestering it inside vesicles away from its mitochondrial site of neurotoxic action. However, the implication of the VMAT2 in the mechanism of action exerted by 6-OHDA has received little attention. Therefore, the aim of the present study was to determine whether the vesicular sequestration of 6-OHDA would protect dopaminergic neurons from its toxicity similarly to what is observed with MPP<sup>+</sup>, We injected mice with 6-OHDA 90 min after TBZ treatment. Since, unexpectedly, TBZ pretreatment prevented 6-OHDA neurotoxicity, we performed a similar experience replacing 6-OHDA with MPP in order to check our experimental protocol. TBZ pretreatment similarly prevented MPP neurotoxicity. This discrepancy with what is commonly describe in the literature, led us to use reserpine. Indeed, the long lasting VMAT2 inhibition induced by reserpine allowed us to inject neurotoxins while mice no longer presented hypothermia. Contrary to TBZ pretreatment, reserpine pretreatment potentiated both 6-OHDA and MPP<sup>+</sup> toxicity on dopaminergic neurons. Hypothermia elicited by TBZ appeared to be responsible, at least in part, for the neuroprotective effect observed. To verify this hypothesis, we investigated the influence of hypothermia on the toxic activity of both neurotoxins. A hypothermia similar to that induced by TBZ was obtained by a forced swimming test of putting mice into cool water (23 °C). The hypothermia prevented both 6-OHDA and MPP<sup>+</sup>-induced neurotoxicity. We finally reported that VMAT2 inhibition potentiates both MPP<sup>+</sup> and 6-OHDA neurotoxicity.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Haute-Normandie</li><li>Région Normandie</li></region><settlement><li>Rouen</li></settlement></list><tree><country name="France"><region name="Région Normandie"><name sortKey="Cleren, Carine" sort="Cleren, Carine" uniqKey="Cleren C" first="Carine" last="Cleren">Carine Cleren</name></region><name sortKey="Costentin, Jean" sort="Costentin, Jean" uniqKey="Costentin J" first="Jean" last="Costentin">Jean Costentin</name><name sortKey="Naudin, Bertrand" sort="Naudin, Bertrand" uniqKey="Naudin B" first="Bertrand" last="Naudin">Bertrand Naudin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003283 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003283 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:04-0022513
|texte= Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons
}}
| This area was generated with Dilib version V0.6.29. |  |